| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Anticoagulation in COVID-19
|
Bradbury, Charlotte A
|
|
|
399 |
10319 |
p. 5-7
|
artikel
|
| 2 |
An urgent challenge for Europe: from tackling liver diseases to protecting liver health
|
Kleinert, Sabine
|
|
|
399 |
10319 |
p. 7-9
|
artikel
|
| 3 |
Brazilian science under continuous attack
|
Galvão-Castro, Bernardo
|
|
|
399 |
10319 |
p. 23-24
|
artikel
|
| 4 |
Caution required with use of ritonavir-boosted PF-07321332 in COVID-19 management
|
Heskin, Joseph
|
|
|
399 |
10319 |
p. 21-22
|
artikel
|
| 5 |
COVID-19 ARDS: getting ventilation right
|
Pérez-Fernández, Xosé L
|
|
|
399 |
10319 |
p. 22
|
artikel
|
| 6 |
COVID-19 ARDS: getting ventilation right – Authors' reply
|
Barbaro, Ryan P
|
|
|
399 |
10319 |
p. 22-23
|
artikel
|
| 7 |
Does it really matter if you win or lose the genetic lottery?
|
Graves Jr, Joseph L
|
|
|
399 |
10319 |
p. 16-17
|
artikel
|
| 8 |
Elihu Harris Estey
|
Watts, Geoff
|
|
|
399 |
10319 |
p. 20
|
artikel
|
| 9 |
HTLV-1 uveitis and Graves' disease presenting with sudden onset of blurred vision
|
Kamoi, Koju
|
|
|
399 |
10319 |
p. 60
|
artikel
|
| 10 |
Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial
|
Stuart, Arabella S V
|
|
|
399 |
10319 |
p. 36-49
|
artikel
|
| 11 |
Liver disease: at the heart of public health challenges for Europe in the 21st century
|
Cooke, Graham S
|
|
|
399 |
10319 |
p. 9-10
|
artikel
|
| 12 |
Managing waning vaccine protection against SARS-CoV-2 variants
|
Leung, Kathy
|
|
|
399 |
10319 |
p. 2-3
|
artikel
|
| 13 |
Médecins Sans Frontières: 50 years of bearing witness
|
Samarasekera, Udani
|
|
|
399 |
10319 |
p. 12-15
|
artikel
|
| 14 |
Mixing mRNA, adenoviral, and spike-adjuvant vaccines for protection against COVID-19
|
Richardson, Christopher D
|
|
|
399 |
10319 |
p. 3-5
|
artikel
|
| 15 |
New INN nomenclature for monoclonal antibodies
|
Balocco, Raffaella
|
|
|
399 |
10319 |
p. 24
|
artikel
|
| 16 |
Offline: The origin story—towards a final resolution?
|
Horton, Richard
|
|
|
399 |
10319 |
p. 11
|
artikel
|
| 17 |
Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial
|
Ramacciotti, Eduardo
|
|
|
399 |
10319 |
p. 50-59
|
artikel
|
| 18 |
Sivaramakrishna Iyer Padmavati: trailblazing cardiologist in India
|
Ferry, Georgina
|
|
|
399 |
10319 |
p. 19
|
artikel
|
| 19 |
The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality
|
Karlsen, Tom H
|
|
|
399 |
10319 |
p. 61-116
|
artikel
|
| 20 |
The state of science and society in 2022
|
The Lancet,
|
|
|
399 |
10319 |
p. 1
|
artikel
|
| 21 |
Tom Hemming Karlsen: hepatologist with a public health message
|
Watts, Geoff
|
|
|
399 |
10319 |
p. 18
|
artikel
|
| 22 |
Two-dose ChAdOx1 nCoV-19 vaccine protection against COVID-19 hospital admissions and deaths over time: a retrospective, population-based cohort study in Scotland and Brazil
|
Katikireddi, Srinivasa Vittal
|
|
|
399 |
10319 |
p. 25-35
|
artikel
|
Tijdschrift beschrijving